论文部分内容阅读
目的探讨血糖水平和高敏C反应蛋白(hs-CRP)对急性冠脉综合征(ACS)患者近期预后的影响。方法对130例ACS患者,根据清晨空腹静脉血糖(FPG)水平分为A组(≤6.1mmol/L)、B组(6.2~10.0mmol/L)、C组(>10.0 mmol/L),测定各组hs-CRP,并对以上资料进行回顾性分析。结果 A、B、C组的hs-CRP水平分别为(4.08±1.35)mg/L、(6.70±1.78)mg/L、(12.53±3.69)mg/L,三组间两两比较,差异均有统计学意义(均P<0.01)。各组之间不良事件发生率比较,差异均有统计学意义(P<0.05或P<0.01)。结论随着FPG水平的升高,ACS患者有更高的hs-CRP水平,近期不良事件的发生率增加。
Objective To investigate the effects of blood glucose and hs-CRP on the short-term prognosis of patients with acute coronary syndrome (ACS). Methods 130 ACS patients were divided into group A (≤6.1mmol / L), group B (6.2 ~ 10.0mmol / L) and group C (> 10.0mmol / L) according to fasting fasting blood glucose (FPG) Each group hs-CRP, and the above data were retrospectively analyzed. Results The levels of hs-CRP in groups A, B and C were (4.08 ± 1.35) mg / L, (6.70 ± 1.78) mg / L and (12.53 ± 3.69) mg / L, There was statistical significance (all P <0.01). The incidence of adverse events between the groups, the differences were statistically significant (P <0.05 or P <0.01). Conclusions With the increase of FPG level, patients with ACS have higher hs-CRP level, and the incidence of adverse events has increased recently.